REGULATORY
MHLW Reports Partial Modifications of Approval for 3 Drugs Including Polidocasklerol to Advisory Panel
The Ministry of Health, Labor and Welfare (MHLW) reported the partial modifications of approval for three active pharmaceutical ingredients (APIs) to its key drug review committee. At a meeting of the Pharmaceutical Affairs and Food Sanitation Council’s First Committee on…
To read the full story
Related Article
- MHLW Panel Backs BI’s Triple Combo After 3rd Try
September 9, 2016
REGULATORY
- 4 Drug Makers Seek Govt Aid to Upgrade Aging Plants: LDP Hearing
August 24, 2026
- 679 Safety Reports Logged for Regenerative Medical Products in 2H FY2025
August 21, 2026
- Japan Panel to Discuss Approval of 6 NMEs, Leqembi SC on Aug. 26
August 20, 2026
- DPP Lawmaker Calls for Inflation Relief in 2027 Off-Year Drug Price Revision
August 19, 2026
- CEA Review Group Wraps Up Technical Debate, Urges More Company Access
August 19, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





